News

Find News

Filter articles

Showing 1 to 10 of 3480 results

Fresenius in patent dispute over hypocalcemia treatment

US07-12-2021Muireann Bolger

Fresenius Kabi is facing a lawsuit by two Pharmasphere subsidiaries over claims that it infringed a patent covering a treatment for hypocalcemia, a condition where the blood sugar level is lower than normal.

Galderma sues Lupin over Oracea generic

US07-12-2021Alex Baldwin

Galderma Laboratories has sued Lupin Pharmaceuticals alleging that it plans to manufacture and sell a generic version of Oracea prior to the expiration of key patents.

J&J secures injunction against medical device counterfeiter

US07-12-2021

Johnson & Johnson’s subsidiary Ethicon has obtained a permanent injunction against counterfeiters selling fake versions of Surgicel, an absorbable haemostat used to control bleeding during surgery.

BGI hit with $8m damages bill in patent dispute with Illumina

02-12-2021Muireann Bolger

Illumina has secured an $8 million damages verdict against China-based BGI Genomics, and its US subsidiary, MGI, in a dispute involving gene-sequencing patents.

Moderna exposed after losing COVID-19 vaccine patent decision

02-12-2021Muireann Bolger

Moderna has failed to reverse an unfavourable ruling related to its COVID-19 vaccine technology, after the US Court of Appeals for the Federal Circuit upheld the validity of a patent owned by Arbutus Biopharma.

Fed Circuit split decision denies Biogen’s bid to revive MS drug patent

02-12-2021

The US Court of Appeals for the Federal Circuit has refused Biogen’s attempt to revive a key patent for its multiple sclerosis drug Tecfidera (dimethyl fumarate), leaving Mylan’s successful challenge intact. 

Biofrontera settles patent dispute with Dusa over skin treatment

US30-11-2021Muireann Bolger

A US subsidiary of German skin treatment company Biofrontera has resolved its dispute with Dusa Pharmaceuticals, on the eve of a trial over patents covering a light therapy used to treat skin conditions, called BLU-U.

Fed Circ says Indivior patent was anticipated

US30-11-2021Alex Baldwin

The US Court of Appeals for the Federal Circuit has affirmed a US Patent Trial and Appeal Board decision that held that claims of a patent for dissolvable films containing therapeutic agents were anticipated.

Omicron variant delays COVID-19 IP waiver debate

International29-11-2021

The World Trade Organization has postponed its ministerial conference indefinitely, potentially ending the opportunity for countries to agree an IP waiver for COVID-19 vaccines this year.

Court denies Sun Pharma’s bid to avoid trial

India, US25-11-2021

Sun Pharma’s bid to avoid facing a trial over allegations of antitrust behaviour by an Indian drugmaker it acquired has been denied by a Massachusetts court.

Showing 1 to 10 of 3480 results

LSIPR